COVID-19 mRNA Vaccine and Myocarditis.
Eur J Case Rep Intern Med
; 8(7): 002681, 2021.
Article
in English
| MEDLINE | ID: covidwho-2281609
ABSTRACT
Coronavirus disease 2019 (COVID-19) is believed to have originated in the Hua nan South China Seafood Market in Wuhan and can present with a spectrum of clinical manifestations. We report the case of 24-year-old male patient who developed chest pain after administration of the second dose of the Pfizer-BioNTech mRNA COVID-19 vaccine and who was diagnosed with myocarditis on work-up. LEARNING POINTS Localized injection site reactions and systemic adverse effects can occur after administration of the various COVID-19 vaccines.Healthcare providers should maintain a high index of suspicion regarding myocarditis after mRNA COVID-19 vaccination in the appropriate clinical scenario.
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Type of study:
Prognostic study
Topics:
Vaccines
Language:
English
Journal:
Eur J Case Rep Intern Med
Year:
2021
Document Type:
Article
Similar
MEDLINE
...
LILACS
LIS